Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - Predictive Oncology Inc.ex31_1.htm
EX-31.2 - EXHIBIT 31.2 - Predictive Oncology Inc.ex31_2.htm
10-Q - FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2015 - Predictive Oncology Inc.j73015010q.htm
Exhibit 32.1
 
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Skyline Medical Inc. (the “Company”) for the quarter ended June 30, 2015 as filed with the Securities and Exchange Commission (the “Report”), I, Joshua Kornberg, Chief Executive Officer (Principal Executive Officer) and, I, Bob Myers, Chief Financial Officer (Principal Financial Officer) of the Company, hereby certify as of the date hereof, solely for purposes of § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to the best of my knowledge:
 
(1)      The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
 
(2)       The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
Date: August 10, 2015
/s/ Joshua Kornberg
 
 
Joshua Kornberg
 
 
Chief Executive Officer
 
Date: August 10, 2015
/s/ Bob Myers
 
 
Bob Myers
 
 
Chief Financial Officer